Assess the risk of chemotherapy-induced nausea and vomiting, then choose the appropriate prophylactic regimen

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.25, Iss.10, 2009-10, pp. : 17-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Palonosetron for chemotherapy-induced nausea and vomiting

By  

Inpharma, Vol. 1, Iss. 1412, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Risk–benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting

By Herrstedt Jørn  

Expert Opinion on Drug Safety, Vol. 3, Iss. 3, 2004-05 ,pp. : 231-248

Informa Healthcare

Access to resources Recommend Favorite

Chemotherapy-induced nausea and vomiting costly in Germany

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 450, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Chemotherapy-induced nausea and vomiting costly in Germany

By  

Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Biobehavioral Factors in Chemotherapy-Induced Nausea and Vomiting

By Roscoe Joseph A.   Morrow Gary R.   Hickok Jane T.   Mustian Karen M.   Shelke Abhay R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 5, 2004-09 ,pp. : 501-508

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite